Zobrazeno 1 - 8 of 8 pro vyhledávání: '"V A S H, Dalm"'
1
Akademický článek
Are Patients at Risk for Recurrent Disease Activity After Switching From Remicade® to Remsima®? An Observational Study
Autor: Laixi Xue, K. van Bilsen, M. W. J. Schreurs, M. E. J. van Velthoven, T. O. Missotten, A. A. H. J. Thiadens, R. W. A. M. Kuijpers, P. van Biezen, V. A. S. H. Dalm, J. A. M. van Laar, M. A. W. Hermans, W. A. Dik, P. L. A. van Daele, P. M. van Hagen
Publikováno v: Frontiers in Medicine, Vol 7 (2020)
Background: Since the late ‘90s, infliximab (Remicade®) is being used successfully to treat patients with several non-infectious immune mediated inflammatory diseases (IMIDs). In recent years, infliximab biosimilars, including Remsima® were intro
Externí odkaz: https://doaj.org/article/e152d3e8b46f4c7a951758b552d87606
Zobrazit plný text záznamu
2
Are Patients at Risk for Recurrent Disease Activity After Switching From Remicade(R)to Remsima(R)? An Observational Study
Autor: Laixi Xue, K. van Bilsen, M. W. J. Schreurs, M. E. J. van Velthoven, T. O. Missotten, A. A. H. J. Thiadens, R. W. A. M. Kuijpers, P. van Biezen, V. A. S. H. Dalm, J. A. M. van Laar, M. A. W. Hermans, W. A. Dik, P. L. A. van Daele, P. M. van Hagen
Publikováno v: Frontiers in Medicine, 7:418. Frontiers Media S.A.
Frontiers in Medicine, Vol 7 (2020)
Frontiers in Medicine
Background: Since the late ‘90s, infliximab (Remicade®) is being used successfully to treat patients with several non-infectious immune mediated inflammatory diseases (IMIDs). In recent years, infliximab biosimilars, including Remsima® were intro
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ba65c21bf17d25fa1100bf43e3827798
https://pure.eur.nl/en/publications/007aabaf-4fdc-4242-9563-c99a7f4f8ee5
Zobrazit plný text záznamu
6
The role of octreotide scintigraphy in rheumatoid arthritis and sarcoidosis
Autor: V A S H, Dalm, P M, van Hagen, E P, Krenning
Publikováno v: The quarterly journal of nuclear medicine : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR). 47(4)
Somatostatin receptors are widely expressed on cells and tissues throughout the human body. Apart from their expression in the physiological target organs of the peptide, somatostatin receptors are also expressed in various tumours. The expression of
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::e1bdb6004999fb87f9e20c36d2e4e6a0
https://pubmed.ncbi.nlm.nih.gov/14973419
Zobrazit plný text záznamu
7
Akademický článek
Did variants in inborn errors of immunity genes contribute to the extinction of Neanderthals?
Autor: Zhou Z; Erasmus MC, University Medical Center Rotterdam, Laboratory Medical Immunology, department of Immunology, the Netherlands.; Erasmus MC, University Medical Center Rotterdam, department of Internal Medicine, Division of Clinical Immunology, the Netherlands.; Erasmus MC, University Medical Center Rotterdam, Academic Center for Rare Immunological Diseases (RIDC), the Netherlands., M A Swagemakers S; Erasmus MC, University Medical Center Rotterdam, department of Pathology, Division of Clinical Bioinformatics, the Netherlands., S Lourens M; Erasmus MC, University Medical Center Rotterdam, Laboratory Medical Immunology, department of Immunology, the Netherlands.; Erasmus MC, University Medical Center Rotterdam, Academic Center for Rare Immunological Diseases (RIDC), the Netherlands., Suratannon N; Erasmus MC, University Medical Center Rotterdam, Laboratory Medical Immunology, department of Immunology, the Netherlands.; Center of Excellence for Allergy and Clinical Immunology, Division of Allergy, Immunology and Rheumatology, Department of Pediatrics, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand., J van der Spek P; Erasmus MC, University Medical Center Rotterdam, department of Pathology, Division of Clinical Bioinformatics, the Netherlands., A S H Dalm V; Erasmus MC, University Medical Center Rotterdam, Laboratory Medical Immunology, department of Immunology, the Netherlands.; Erasmus MC, University Medical Center Rotterdam, department of Internal Medicine, Division of Clinical Immunology, the Netherlands.; Erasmus MC, University Medical Center Rotterdam, Academic Center for Rare Immunological Diseases (RIDC), the Netherlands., A Dik W; Erasmus MC, University Medical Center Rotterdam, Laboratory Medical Immunology, department of Immunology, the Netherlands.; Erasmus MC, University Medical Center Rotterdam, Academic Center for Rare Immunological Diseases (RIDC), the Netherlands., IJspeert H; Erasmus MC, University Medical Center Rotterdam, Laboratory Medical Immunology, department of Immunology, the Netherlands.; Erasmus MC, University Medical Center Rotterdam, Academic Center for Rare Immunological Diseases (RIDC), the Netherlands., van Hagen PM; Erasmus MC, University Medical Center Rotterdam, Laboratory Medical Immunology, department of Immunology, the Netherlands.; Erasmus MC, University Medical Center Rotterdam, department of Internal Medicine, Division of Clinical Immunology, the Netherlands.; Center of Excellence for Allergy and Clinical Immunology, Division of Allergy, Immunology and Rheumatology, Department of Pediatrics, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.; Erasmus MC, University Medical Center Rotterdam, Academic Center for Rare Immunological Diseases (RIDC), the Netherlands.
Publikováno v: Asian Pacific journal of allergy and immunology [Asian Pac J Allergy Immunol] 2022 Dec; Vol. 40 (4), pp. 422-434.
Zobrazit plný text záznamu
8
Akademický článek
A pilot study on the use of prednisolone-encapsulated liposomes for the treatment of moderate-to-severe Graves' orbitopathy with reduced systemic steroid exposure.
Autor: Detiger SE; The Rotterdam Eye Hospital, Rotterdam, the Netherlands., Kremer TM; The Rotterdam Eye Hospital, Rotterdam, the Netherlands., A S H Dalm V; Department of Internal Medicine, Division of Clinical Immunology & Department of Immunology, Erasmus University Medical Center Rotterdam, Rotterdam, the Netherlands., de Keizer ROB; The Rotterdam Eye Hospital, Division of Oculoplastic, Orbital and Lacrimal Surgery, Rotterdam, the Netherlands., Wubbels RJ; The Rotterdam Ophthalmic Institute, Rotterdam, the Netherlands., Metselaar JM; Institute for Experimental Molecular Imaging, RWTH Aachen University Clinic, Forckenbeckstrasse 55, 52074 Aachen, Germany., van Hagen PM; Department of Internal Medicine, Division of Clinical Immunology & Department of Immunology, Erasmus University Medical Center Rotterdam, Rotterdam, the Netherlands., Peeters RP; Department of Internal Medicine, Division of Endocrinology, Erasmus University Medical Center Rotterdam, Rotterdam, the Netherlands., Paridaens D; The Rotterdam Eye Hospital, Division of Oculoplastic, Orbital and Lacrimal Surgery, Rotterdam, the Netherlands.; Department of Ophthalmology, Erasmus Medical Center Rotterdam, Rotterdam, the Netherlands.
Publikováno v: Acta ophthalmologica [Acta Ophthalmol] 2021 Nov; Vol. 99 (7), pp. 797-804. Date of Electronic Publication: 2021 Jan 10.
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje